Latest Us Expansion News

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Inventis Limited reported solid Q3 cash generation and strong technology sales growth, while actively pursuing international expansion and a $2.5 million USD capital raise for its US Hazavoid entity.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Global Uranium and Enrichment Limited has completed a transformative acquisition of the Pine Ridge Uranium Project in Wyoming, backed by a A$10 million capital raise and strategic partnership with Snow Lake Energy. This positions the company for near-term uranium production in the US’s premier ISR basin while advancing multiple other uranium assets.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Australian Strategic Materials (ASM) has made significant strides in its mine to metals strategy during the March 2025 quarter, including plans for US expansion and progress at its Dubbo Project and Korean Metals Plant. The company is positioning itself as a key alternative supply chain amid escalating geopolitical tensions and export restrictions.

Identitii Limited advances its BNDRY platform with new agreements targeting hospitality and payments sectors, appoints Tim Phillipps as Executive Chair, and reports stable cash flow amid ongoing patent litigation.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.

ARB Corporation Limited posted a 5.9% rise in sales revenue to $361.7 million for 1H FY2025, driven by strong export growth, while profit before tax edged down 0.7% amid rising costs and subdued domestic vehicle sales.

ARB Corporation Limited reported a 5.9% increase in sales revenue to $361.7 million for the half year ended December 2024, while profit margins slightly contracted. Strategic acquisitions in the US and Australasia underpin the company’s cautious optimism for future growth.

Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.